search icon
  • Print
  • ShareThis
  • Text Size
  • Federal Funding for Infectious Diseases Programs


    Today’s investment in ID research; public health and prevention; and development of new drugs, vaccines and diagnostics will pay significant dividends in the future. Such investments can prevent needless deaths, dramatically reduce health care costs, and improve the quality of life for millions of Americans and others around the world.  IDSA supports appropriate funding for domestic and international programs including those at the:

    • National Institute for Allergies and Infectious Diseases 
    • Centers for Disease Control and Prevention  
    • Food and Drug Administration 
    • Health Resources Services Administration 
    • U.S. Agency for International Development 
    • National Institute of Health’s Fogarty International Center 


    IDSA’s funding priorities include antimicrobial resistance; immunizations; drug, vaccine and diagnostics development; and HIV/AIDS and tuberculosis prevention and treatment.


    See also:

    HIVMA Federal Funding

    IDSA's Efforts in Advocating for Appropriate Federal Funding for Infectious Diseases Programs


    Need for Antibiotic Resistance Funding Featured in Testimony on FY 2016 (PDF)

    IDSA provided testimony on 2016 funding for infectious diseases priorities to the House subcommittee that has oversight of health spending. The need for funding to implement the National Action Plan for Combating Antibiotic-Resistant Bacteria was featured in the statement.

    IDSA Engages the Senate on 2016 Infectious Diseases Funding Needs (PDF)

    IDSA provided testimony to the Senate panel that oversees federal spending on health programs. The statement encouraged the subcommittee to invest in areas such as antibiotic resistance, rapid diagnostics, immunizations, global health, and neglected tropical diseases.

    IDSA Provides Testimony for Senate Hearing on Ebola Funding (PDF)

    IDSA provided testimony to the Senate Appropriations Committee in support of President Obama's request for emergency funds to deal with the Ebola outbreak.  The Committee solicited stakeholder input ahead of a hearing to discuss the President's request.

    IDSA Provides Testimony on Innovation to the Senate (PDF)

    In preparation for a Senate hearing on the federal role in promoting innovation, IDSA provided testimony on the health and economic gains possible from new public health strategies, vaccines, antibiotics, and rapid diagnostics.

    IDSA and Pew Call on Health Spending Panel Leaders to Fund Antibiotic Resistance Proposals (PDF)

    IDSA and the Pew Charitable Trusts wrote to leaders of the House and Senate subcommittees charged with appropriating funding for health agencies to fully fund the President's plan to combat antibiotic resistance.

    IDSA President Calls on Policymakers to Protect the Prevention and Public Health Fund (PDF)

    Dr. Johan Bakken joined leaders from more than 60 other organizations in a letter to President Obama asking that any budget agreement developed with Congress include continued support for the Prevention and Public Health Fund.  The Prevention Fund, established by the Affordable Care Act, provides much needed support for a host of programs, including Section 317 immunizations and Epidemiology and Laboratory Capacity Grants.

    IDSA Joins Call for Food Safety Funding (PDF)

    Twenty groups joined in a letter to House and Senate appropriators that called for sufficient funding to fully implement the FDA Food and Safety Modernization Act (FSMA), which strengthens and modernizes regulatory, administrative, and information-technology systems.

    IDSA Leads Stakeholder Letter Urging a Budget Compromise and Increased Appropriations (PDF)

    IDSA was joined by 42 other organizations in a letter to House and Senate appropriators that urged support for a budget compromise and increased appropriations for activities to address antimicrobial resistance.

    Groups Seek Support for Global TB Activities in Anticipation of FY2014 Funding Bill Release (PDF)

    IDSA joined other stakeholders in a letter to Congress seeking $236 million for USAID's TB programs in FY2014.  The letter discusses the impact of TB around the globe and makes special note of the emergence of multidrug-resistant and extensively drug-resistant TB.  USAID is a central partner in efforts to control TB in the world's 30 most highly burdened countries.

    Community Letter Advocating Robust Global Health Efforts (PDF)

    IDSA joined 53 other organizations to urge lawmakers to maintain its funding commitments to improving health in developing countries, without cutting other broader humanitarian efforts and development or imposing any new policy restrictions.

    TB Coalition Letter for Global and Domestic TB Funding (PDF)

    IDSA joined 16 other organizations to urge lawmakers to strengthen U.S. leadership in the fight against TB as envisioned in the Lantos-Hyde Act and Comprehensive TB Elimination Act by investing in global and domestic TB programs at USAID and CDC.

| HIVMA | Contact Us

© Copyright IDSA 2016 Infectious Diseases Society of America

Full Site Mobile Site